159.79 USD
▲+0.53+0.60%
2026-08-03
市值
$21.44B
市盈率
—
EPS
-3.50
股息率
—
52 周区间
41.19 – 176.58
成交量
2.19M
Beta
1.59
目标价
187.50
52W 低 41.1952W 高 176.58
价格走势
公司简介
Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally. The company offers Guardant360 CDx test, a liquid biopsy test for tumor mutation profiling; Guardant360 Liquid test, which measures 740+ genes and supports all guideline-recommended biomarkers; Guardant Reveal test, a blood test that utilizes circulating tumor DNA to detect cancer at the molecular level; and Guardant360 Tissue test, a molecular profiling test for tumor tissue that provides genomic, transc...